Replies to post #22510 on PharmaCyte Biotech Inc (PMCB)

[Peacefulwendy]

I invested in Nuvilex and I have taken the time to do my DD. I expect a healthy return in the end as we heard today that TD2, who has already had successful FDA trials and whose business model is to choose companies with a good chance of success, has decided to go for all abdominal cancers. Just cover it all in one FDA approval. Pretty significant to this "investor". And I am quite proud to be one as well.

Everyone has their own agenda. Mine is to stay right here and see this through to successful trials. I expect to see those soon as I have done my DD.

From what I am reading between the lines, TD2 is pretty confident as they are seeking more and more clinical uses for CiaB. That is pretty amazing to me!

GLTU

NVLX ~ Cell-in-a-Box(R)

[$Pistol Pete$]

Dear crackcorn,

If you haven't do your own DD of this company. I think it is not fair for us to allow you to post your non-relevant idea. Please help to study about this company first before you post please.

Best Regards,

Peter Pham

[bulldurham]

So you are saying no one should invest in a small bio on the cusp of getting an approval going into phase 2b trials...because they are going for approval after the 2b trial...not a large phase 3...so you are saying not to invest...well I think you should take your own advice...I advise no one else to do that...have you ever been invested in small bio's before...

bull